featured
Association of GLP-1/Glucagon Receptor Agonism With Reduced Metabolic Adaptation and Higher Fat Oxidation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Obesity
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial
Obesity 2023 Feb 01;31(2)350-362, KD Corbin, EA Carnero, TD Allerton, J Tillner, CP Bock, PP Luyet, B Göbel, KD Hall, SA Parsons, E Ravussin, SR SmithFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.